相似文献
1
Laboratory-based surveillance of extensively drug-resistant tuberculosis, China.
Emerg Infect Dis. 2011 Mar;17(3):495-7. doi: 10.3201/eid1703.100812.
2
Correlations between drug resistance of Beijing/W lineage clinical isolates of Mycobacterium tuberculosis and sublineages: a 2009-2013 prospective study in Xinjiang province, China.
Med Sci Monit. 2015 May 7;21:1313-8. doi: 10.12659/MSM.892951.
3
Extensively drug-resistant tuberculosis in california, 1993-2006.
Clin Infect Dis. 2008 Aug 15;47(4):450-7. doi: 10.1086/590009.
4
Extensively drug-resistant tuberculosis, China.
Emerg Infect Dis. 2011 Mar;17(3):558-60. doi: 10.3201/eid1703.100919.
5
Population-based surveillance of extensively drug-resistant tuberculosis in Shandong Province, China.
Int J Tuberc Lung Dis. 2012 May;16(5):612-4. doi: 10.5588/ijtld.11.0507. Epub 2012 Mar 7.
6
Concomitant increases in spectrum and level of drug resistance in Mycobacterium tuberculosis isolates.
Int J Tuberc Lung Dis. 2010 Nov;14(11):1436-41, i.
7
Drug Resistance Characteristics of Isolates From Patients With Tuberculosis to 12 Antituberculous Drugs in China.
Front Cell Infect Microbiol. 2019 Nov 5;9:345. doi: 10.3389/fcimb.2019.00345. eCollection 2019.
8
Increasing drug resistance in extensively drug-resistant tuberculosis, South Africa.
Emerg Infect Dis. 2011 Mar;17(3):510-3. doi: 10.3201/eid1703.101363.
9
Trends in Mycobacterium tuberculosis resistance, Pakistan, 1990-2007.
Int J Infect Dis. 2009 Nov;13(6):e377-82. doi: 10.1016/j.ijid.2009.01.008. Epub 2009 Apr 14.
10
Comparison of the socio-demographic and clinical features of pulmonary TB patients infected with sub-lineages within the W-Beijing and non-Beijing Mycobacterium tuberculosis.
Tuberculosis (Edinb). 2016 Mar;97:18-25. doi: 10.1016/j.tube.2015.11.007. Epub 2015 Dec 23.
引用本文的文献
1
Global prevalence of drug-resistant tuberculosis: a systematic review and meta-analysis.
Infect Dis Poverty. 2023 May 25;12(1):57. doi: 10.1186/s40249-023-01107-x.
2
Determination of critical concentration for drug susceptibility testing of Mycobacterium tuberculosis against para-aminosalicylic acid with clinical isolates with thyA, folC and dfrA mutations.
Ann Clin Microbiol Antimicrob. 2022 Nov 5;21(1):48. doi: 10.1186/s12941-022-00537-z.
3
Risk Factor for Retreatment Episode on Admission Among TB Patients With Schizophrenia.
Front Psychiatry. 2021 Dec 9;12:793470. doi: 10.3389/fpsyt.2021.793470. eCollection 2021.
4
Prevalence of Antibiotic-Resistant Pulmonary Tuberculosis in Bangladesh: A Systematic Review and Meta-Analysis.
Antibiotics (Basel). 2020 Oct 17;9(10):710. doi: 10.3390/antibiotics9100710.
5
Risk factors for tuberculous empyema in pleural tuberculosis patients.
Sci Rep. 2019 Dec 20;9(1):19569. doi: 10.1038/s41598-019-56140-4.
6
Risk Factors for False-Negative Interferon-γ Release Assay Results in Culture-Confirmed Childhood TB.
Am J Trop Med Hyg. 2019 Dec;101(6):1303-1307. doi: 10.4269/ajtmh.18-0684.
7
Prevalence of multidrug-resistant tuberculosis in suspected childhood tuberculosis in Shandong, China: a laboratory-based study.
J Int Med Res. 2020 Jan;48(1):300060519869715. doi: 10.1177/0300060519869715. Epub 2019 Sep 20.
8
Prevalence, risk and genetic characteristics of drug-resistant tuberculosis in a tertiary care tuberculosis hospital in China.
Infect Drug Resist. 2019 Aug 7;12:2457-2465. doi: 10.2147/IDR.S209971. eCollection 2019.
9
Transmission is a Noticeable Cause of Resistance Among Treated Tuberculosis Patients in Shanghai, China.
Sci Rep. 2017 Aug 9;7(1):7691. doi: 10.1038/s41598-017-08061-3.
10
Prevalence and risk factors of multi-drug resistant tuberculosis in Dalian, China.
J Int Med Res. 2017 Dec;45(6):1779-1786. doi: 10.1177/0300060516687429. Epub 2017 Mar 27.
本文引用的文献
1
Epidemiology of antituberculosis drug resistance 2002-07: an updated analysis of the Global Project on Anti-Tuberculosis Drug Resistance Surveillance.
Lancet. 2009 May 30;373(9678):1861-73. doi: 10.1016/S0140-6736(09)60331-7. Epub 2009 Apr 15.
2
Transmission of MDR and XDR tuberculosis in Shanghai, China.
PLoS One. 2009;4(2):e4370. doi: 10.1371/journal.pone.0004370. Epub 2009 Feb 3.
3
Characterization of extensively drug-resistant Mycobacterium tuberculosis clinical isolates in China.
J Clin Microbiol. 2008 Dec;46(12):4075-7. doi: 10.1128/JCM.00822-08. Epub 2008 Oct 22.
4
Worldwide emergence of extensively drug-resistant tuberculosis.
Emerg Infect Dis. 2007 Mar;13(3):380-7. doi: 10.3201/eid1303.061400.
5
XDR tuberculosis--implications for global public health.
N Engl J Med. 2007 Feb 15;356(7):656-9. doi: 10.1056/NEJMp068273.
6
Drug-susceptibility testing in tuberculosis: methods and reliability of results.
Eur Respir J. 2005 Mar;25(3):564-9. doi: 10.1183/09031936.05.00111304.
7
Is second-line anti-tuberculosis drug susceptibility testing reliable?
Int J Tuberc Lung Dis. 2004 Sep;8(9):1157-8.
Zotero 插件